These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 22164265

  • 1. Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway.
    Finsen AV, Lunde IG, Sjaastad I, Østli EK, Lyngra M, Jarstadmarken HO, Hasic A, Nygård S, Wilcox-Adelman SA, Goetinck PF, Lyberg T, Skrbic B, Florholmen G, Tønnessen T, Louch WE, Djurovic S, Carlson CR, Christensen G.
    PLoS One; 2011; 6(12):e28302. PubMed ID: 22164265
    [Abstract] [Full Text] [Related]

  • 2. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
    Lunde IG, Aronsen JM, Melleby AO, Strand ME, Skogestad J, Bendiksen BA, Ahmed MS, Sjaastad I, Attramadal H, Carlson CR, Christensen G.
    Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
    [Abstract] [Full Text] [Related]

  • 3. Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress.
    Herum KM, Lunde IG, Skrbic B, Florholmen G, Behmen D, Sjaastad I, Carlson CR, Gomez MF, Christensen G.
    J Mol Cell Cardiol; 2013 Jan; 54():73-81. PubMed ID: 23178899
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
    Donaldson C, Eder S, Baker C, Aronovitz MJ, Weiss AD, Hall-Porter M, Wang F, Ackerman A, Karas RH, Molkentin JD, Patten RD.
    Circ Res; 2009 Jan 30; 104(2):265-75, 11p following 275. PubMed ID: 19074476
    [Abstract] [Full Text] [Related]

  • 7. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.
    Luo Y, Jiang N, May HI, Luo X, Ferdous A, Schiattarella GG, Chen G, Li Q, Li C, Rothermel BA, Jiang D, Lavandero S, Gillette TG, Hill JA.
    Circulation; 2021 Jul 06; 144(1):34-51. PubMed ID: 33821668
    [Abstract] [Full Text] [Related]

  • 8. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
    Echtermeyer F, Harendza T, Hubrich S, Lorenz A, Herzog C, Mueller M, Schmitz M, Grund A, Larmann J, Stypmann J, Schieffer B, Lichtinghagen R, Hilfiker-Kleiner D, Wollert KC, Heineke J, Theilmeier G.
    Cardiovasc Res; 2011 Oct 01; 92(1):123-31. PubMed ID: 21632883
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
    Herum KM, Lunde IG, Skrbic B, Louch WE, Hasic A, Boye S, Unger A, Brorson SH, Sjaastad I, Tønnessen T, Linke WA, Gomez MF, Christensen G.
    Cardiovasc Res; 2015 May 01; 106(2):217-26. PubMed ID: 25587045
    [Abstract] [Full Text] [Related]

  • 12. Activation of the calcineurin/NFAT signalling cascade starts early in human hypertrophic myocardium.
    Diedrichs H, Hagemeister J, Chi M, Boelck B, Müller-Ehmsen J, Schneider CA.
    J Int Med Res; 2007 May 01; 35(6):803-18. PubMed ID: 18034994
    [Abstract] [Full Text] [Related]

  • 13. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA, Barakat AZ, Zimmermann WH, Bittner RE, Mühlfeld C, Hünlich M, Engel W, Maier LS, Adham IM.
    J Mol Cell Cardiol; 2012 Oct 01; 53(4):459-68. PubMed ID: 22884543
    [Abstract] [Full Text] [Related]

  • 14. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A, Szaroszyk M, Döppner JK, Malek Mohammadi M, Kattih B, Korf-Klingebiel M, Gigina A, Scherr M, Kensah G, Jara-Avaca M, Gruh I, Martin U, Wollert KC, Gohla A, Katus HA, Müller OJ, Bauersachs J, Heineke J.
    Cardiovasc Res; 2019 Jan 01; 115(1):71-82. PubMed ID: 29931050
    [Abstract] [Full Text] [Related]

  • 15. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B, Bueno OF, Dai YS, Wilkins BJ, Molkentin JD.
    Mol Cell Biol; 2005 Feb 01; 25(3):865-78. PubMed ID: 15657416
    [Abstract] [Full Text] [Related]

  • 16. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS, Huang CH, Chieng H, Chang YT, Chang D, Chen JJ, Chen YC, Chen YH, Shin HS, Campbell KP, Chen CC.
    Circ Res; 2009 Feb 27; 104(4):522-30. PubMed ID: 19122177
    [Abstract] [Full Text] [Related]

  • 17. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling.
    Liu Q, Chen Y, Auger-Messier M, Molkentin JD.
    Circ Res; 2012 Apr 13; 110(8):1077-86. PubMed ID: 22403241
    [Abstract] [Full Text] [Related]

  • 18. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway.
    Rana OR, Saygili E, Meyer C, Gemein C, Krüttgen A, Andrzejewski MG, Ludwig A, Schotten U, Schwinger RH, Weber C, Weis J, Mischke K, Rassaf T, Kelm M, Schauerte P.
    J Mol Cell Cardiol; 2009 Apr 13; 46(4):568-78. PubMed ID: 19150448
    [Abstract] [Full Text] [Related]

  • 19. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
    Oliveira RS, Ferreira JC, Gomes ER, Paixão NA, Rolim NP, Medeiros A, Guatimosim S, Brum PC.
    J Physiol; 2009 Aug 01; 587(Pt 15):3899-910. PubMed ID: 19505981
    [Abstract] [Full Text] [Related]

  • 20. FHL2 binds calcineurin and represses pathological cardiac growth.
    Hojayev B, Rothermel BA, Gillette TG, Hill JA.
    Mol Cell Biol; 2012 Oct 01; 32(19):4025-34. PubMed ID: 22851699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.